Last reviewed · How we verify

NCT03610763

Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair

Recruiting now NA Last updated 12 June 2024
What this trial tests

NA trial testing Transcranial Direct Current Stimulation in Hand Transplantation in 180 participants. Currently enrolling.

Timeline
15 August 2018
Primary endpoint
1 June 2025
1 June 2025

Quick facts

Lead sponsorUniversity of Missouri-Columbia
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment180
Start date15 August 2018
Primary completion1 June 2025
Estimated completion1 June 2025
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Missouri-Columbia

Who can join

18 and older, any sex, with Hand Transplantation or Peripheral Nerve Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study adopts a strategy that has arisen from basic neuroscience research on facilitating adaptive brain plasticity and applies this to rehabilitation to improve functional recovery in peripheral nervous system injuries (including hand transplantation, hand replantation, and surgically repaired upper extremity nerve injuries). The technique involves combining behavioral training with transcranial direct current stimulation (tDCS)-a non-invasive form of brain stimulation capable of facilitating adaptive changes in brain organization.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcranial Direct Current Stimulation

Trials testing the same drug.

Other University of Missouri-Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03610763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing